Jump to content

Pages without language links

The following pages do not link to other language versions.

Showing below up to 50 results in range #651 to #700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Karslıoğlu, I
  2. Kashaninia, Z
  3. Kasperzyk, JL
  4. Kassem, M
  5. Kasseroller, R
  6. Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer
  7. Katz, A
  8. Kaul, R
  9. Kazemian, A
  10. Keefe FJ
  11. Kelleners-Smeets, NWJ
  12. Keller, J
  13. Keller, SM
  14. Keshavarzi, Z
  15. Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer
  16. Kessels, J
  17. Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial
  18. Khan, QJ
  19. Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial
  20. Khodabakhshi, A
  21. Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study
  22. Khodadad, K
  23. Khoundabi, B
  24. Khuri, FR
  25. Kim, DH
  26. Kim, EH
  27. Kimler, BF
  28. King, C
  29. Kirby, A
  30. Kirshner, J
  31. Kirste, S
  32. Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
  33. Kirstein, MN
  34. Kisters, K
  35. Kitajima, M
  36. Klasson, C
  37. Kleckner, AS
  38. Klein, W
  39. Klemp, JR
  40. Ko, YD
  41. Kobayashi, T
  42. Kobayashi T
  43. Kodras, B
  44. Koh, K X
  45. Kohaf, NA
  46. Kohaf NA
  47. Kohli, S
  48. Kohlmann, T
  49. Konmun, J
  50. Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy

View ( | ) (20 | 50 | 100 | 250 | 500)